Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant IDH1 antibody (AA 281-414)

This anti-IDH1 antibody is a Rabbit Monoclonal antibody detecting IDH1 in IHC (f). Suitable for Human.
Catalog No. ABIN7126537

Quick Overview for Recombinant IDH1 antibody (AA 281-414) (ABIN7126537)

Target

See all IDH1 Antibodies
IDH1 (Isocitrate Dehydrogenase 1 (NADP+), Soluble (IDH1))

Antibody Type

Recombinant Antibody

Reactivity

  • 133
  • 69
  • 48
  • 8
  • 7
  • 7
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
Human

Host

  • 97
  • 57
  • 3
  • 1
Rabbit

Clonality

  • 89
  • 69
Monoclonal

Conjugate

  • 100
  • 11
  • 10
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This IDH1 antibody is un-conjugated

Application

  • 112
  • 63
  • 36
  • 34
  • 34
  • 30
  • 28
  • 15
  • 13
  • 8
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Binding Specificity

    • 15
    • 14
    • 12
    • 10
    • 6
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 281-414

    Specificity

    IDH1 R132H antibody binds to IDH1-mutated protein, but does not bind the wild-type IDH1 protein. IDH1 R132H point mutations are frequently seen in World Health Organization grade II and III gliomas and are believed to constitute an early step in tumorigenesis. IDH1 R132H can be used as a diagnostic marker to help differentiate infiltrating gliomas from gliosis, and as a prognostic marker for gliomas and secondary glioblastoma multiforme. IDH1 R132H antibody shows strong cytoplasmic staining and weaker nuclear staining in tumor cells with the R132H-mutated peptide. Diffuse staining of the fibrillary tumor matrix is also seen.

    Cross-Reactivity (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant fragment of human IDH1 protein (around aa 281-414) (exact sequence is proprietary)

    Isotype

    IgG
  • Application Notes

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: HepG2, HeLa, HT29 or MCF7cells. Humanbreast, colon or prostate carcinoma.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    IDH1 (Isocitrate Dehydrogenase 1 (NADP+), Soluble (IDH1))

    Alternative Name

    IDH1

    Background

    Cytosolic NADP-isocitrate dehydrogenase, Epididymis luminal protein 216, Epididymis secretory protein Li 26, HEL-216, HEL-S-26, ICDH, IDCD, IDH1, IDP, IDPC, Isocitrate dehydrogenase 1 (NADP+) soluble, NADP dependent isocitrate dehydrogenase peroxisomal, NADP(+)-specific ICDH, Oxalosuccinate decarboxylase, PICD,IDH1-R132H (Isocitrate Dehydrogenase)
    Cellular localisation: Cytoplasm. Nucleus.

    Molecular Weight

    45-47kDa

    Gene ID

    3417, 593422

    UniProt

    O75874

    Pathways

    Warburg Effect
You are here:
Chat with us!